Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page’s revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the study record. This update does not alter the study details or user-facing information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing v3.6.5. This represents a minor update to the page's template or content and does not alter study details or functionality.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating an updated version of the study details page.SummaryDifference0.0%

- Check55 days agoChange DetectedNew revision label 'Revision: v3.6.4' appears on the page, replacing the previous 'Revision: v3.6.3'. This signals an update to the page’s platform or rendering metadata.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, reflecting a new version of the page's build metadata.SummaryDifference0.0%

- Check98 days agoChange DetectedThe study page now shows recruitment status changes and adds new user guidance sections. It also includes a formatting adjustment to the Intervention/Treatment label.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.